These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2858551)

  • 1. The effect of 6-oxo-prostaglandin E1 on human platelet aggregation in whole blood in-vitro.
    Wilsoncroft PS; Lofts FJ; Griffiths RJ; Moore PK
    J Pharm Pharmacol; 1985 Feb; 37(2):139-41. PubMed ID: 2858551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV; Aiken JW; Shebuski RJ; Gorman RR
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of some pharmacological actions of prostaglandin E1, 6-oxo-PGE1 and PGI2.
    Adaikan PG; Tai NY; Lau LC; Karim SM; Kottegoda SR
    Prostaglandins; 1984 Apr; 27(4):505-16. PubMed ID: 6203140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
    McGiff JC; Spokas EG; Wong PY
    Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of platelet aggregation by the filtration pressure method (author's transl)].
    Matsubara I
    Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):173-84. PubMed ID: 7035311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ; Moore PK
    Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoids and hemostasis in chickens: anti-aggregating activity of prostaglandins E1 and E2, but not of prostacyclin and prostaglandin D2.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Prostaglandins; 1981 Jun; 21(6):1045-58. PubMed ID: 7027319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
    Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U; Stahl T; Hackenthal E
    Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
    Oyekan AO; Botting JH
    Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G; Silver MJ; de Gaetano G
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
    Fitscha P; Kaliman J; Sinzinger H
    Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.
    Casals-Stenzel J; Buse M; Losert W
    Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent changes in the synthesis and catabolism of 6 oxo PGE1 and other prostanoids by the rat kidney in vitro.
    Griffiths RJ; Berry CN; Hoult JR; Moore PK
    Biochem Pharmacol; 1985 Jan; 34(2):223-8. PubMed ID: 3881101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of 6-oxo-PGE1 on the renin-angiotensin-aldosterone system, blood pressure and platelet aggregability in man].
    Morise T; Miyamori I; Ikeda M; Takeda Y; Koshida H; Yasuhara S; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1138-44. PubMed ID: 6686560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the inhibitory effect of E-prostaglandins in human and rabbit platelet-rich plasma and washed platelets.
    Kobzar G; Mardla V; Järving I; Lõhmus M; Vahemets A; Samel N; Lille U
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Oct; 106(2):489-94. PubMed ID: 7904921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.